Table 4.
Validation metrics in sensitivity analysis.
| Metric | ACC/AHA ASCVD function (optimal threshold, 8.2%) | 2008 FHS global CVD function (optimal threshold, 13.6%) |
|---|---|---|
| Sensitivity | 54.0% (95% CI, 35.5%-71.4%) | 53.3% (95% CI, 34.8%-71.0%) |
| Specificity | 50.9% (95% CI, 38.2%-63.8%) | 56.4% (95% CI, 43.4%-69.3%) |
| PPV | 37.2% (95% CI, 22.0%-53.2%) | 40.0% (95% CI, 25.5%-56.7%) |
| NPV | 66.6% (95% CI, 52.3%-80.5%) | 68.9% (95% CI, 54.5%-82.6%) |
ACC/AHA, American College of Cardiology/American Heart Association; ASCVD, atherosclerotic cardiovascular disease; FHS, Framingham Heart Study; CI, confidence interval; CVD, cardiovascular disease risk calculator; NPV, negative predictive value; PPV, positive predictive value.